<DOC>
	<DOCNO>NCT01883921</DOCNO>
	<brief_summary>Primary : - Demonstrate utility electronic data capture ( EDC ) system ( CareExchange™ ) use infusion nurse patient measure physical , quality life ( QOL ) , respiratory , laboratory , disability assessment patient Primary Immunodeficiency Disease ( PIDD ) . Secondary : - Change Intravenous/Subcutaneous Immunoglobulin ( IVIg/SCIg ) dose effect measure outcomes . - Change IVIg/SCIg dose time effect measure outcomes . - Change patient status reflect measure outcome . - Assess value physician collect outcomes data . - Identify type patient response IVIg/SCIg therapy ( well maintain , problematic , etc. ) . - Change response rate measure outcomes IVIg/SCIg therapy disease state , co-morbidities , demographic .</brief_summary>
	<brief_title>Gamma Globulin Observations Outcomes Database Patients With Primary Immunodeficiency Disease ( GOOD-SHEPARD-PI )</brief_title>
	<detailed_description>This prospective , observational evaluation immunoglobulin ( Ig ) therapy consent PIDD adult assent pediatric subject receive infusion service AxelaCare Health Solutions , LLC . Subjects meet inclusion criterion provide informed consent/assent trial participation validate , physician-prescribed , standard-of-care outcome measure , Ig administration information record normal home infusion visit . There also standard-of-care question capture within outcome measure record normal home infusion visit may frequency and/or combination may consider routine clinical care physicians treat medical condition . Collected data de-identified aggregated cohort like diagnosis trend analysis .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<criteria>Diagnosis form Primary Immunodeficiency Disease Age enrollment ≥ 7 Sign inform consent/assented participation Ability read write English Understanding study procedure ability comply study procedure entire length study Receiving Ig discretion patient 's treat physician accordance standard treatment practice Have dos Ig discretion patient 's treat physician accordance standard treatment practice Being consider prescribe Ig discretion patient 's treat physician accordance standard treatment practice Determined eligible infusion service AxelaCare Health Solutions , LLC . collaboration patient 's prescribing physician Children ( age ≤ 6 year ) Prisoners , ward state Determined noncompetency data collection requirement ( physical assessment use iPAD™ ) study participant 's caregiver</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Primary Immunodeficiency</keyword>
	<keyword>Immunodeficiencies</keyword>
	<keyword>Primary Immunodeficiency Diseases</keyword>
	<keyword>PIDD</keyword>
	<keyword>CVID</keyword>
	<keyword>PI</keyword>
	<keyword>Common Variable Immunodeficiency</keyword>
	<keyword>Hypogammaglobulinemia</keyword>
	<keyword>Acquired Hypogammaglobulinemia</keyword>
	<keyword>Immunology</keyword>
	<keyword>Autoimmune Deficiency</keyword>
	<keyword>Intravenous Immunoglobulin</keyword>
	<keyword>Subcutaneous Immunoglobulin</keyword>
	<keyword>IVIg</keyword>
	<keyword>SCIg</keyword>
	<keyword>Immune Globulin</keyword>
	<keyword>Outcomes Research</keyword>
	<keyword>Immunodeficiency</keyword>
</DOC>